Imunon
IMNN
34 hedge funds and large institutions have $3.76M invested in Imunon in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 10 closing their positions.
115% more call options, than puts
Call options by funds: $140K | Put options by funds: $65K
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
0.01% more ownership
Funds ownership: 0.07% → 0.08% (+0.01%)
8% less funds holding
Funds holding: 37 → 34 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
75% less capital invested
Capital invested by funds: $15.2M → $3.76M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$871K |
| 2 |
Two Sigma Advisers
New York
|
+$487K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$350K |
| 4 |
VF
Virtu Financial
New York
|
+$216K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$203K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$664K |
| 2 |
Renaissance Technologies
New York
|
-$652K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$125K |
| 4 |
Two Sigma Investments
New York
|
-$104K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$97.3K |
IMNN Hedge Fund Activity: Q3 2020 in Review
34 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2020, worth a combined $3.76M — down 75% from $15.2M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of IMNN and 7 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 11 added.
The largest buyer was Morgan Stanley, adding an estimated $871K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $664K sold.
- 34 institutional investors held Imunon (IMNN) as of Q3 2020, down from 37 in Q2 2020.
- Funds reported $3.76M of Imunon stock for Q3 2020, down 75% quarter-over-quarter.
- 7 funds opened new Imunon positions in Q3 2020 and 10 closed out, a net change of -3 holders.
- The largest Imunon buyer in Q3 2020 was Morgan Stanley, an estimated $871K added.
- The largest Imunon seller in Q3 2020 was Worth Venture Partners, an estimated $664K sold.
Based on aggregated 13F filings for Q3 2020.